Brief: Ceapro Q3 Sales C$2.908 Million
13/11/2019 14:15
Nov 13 (Reuters) - Ceapro Inc CZO.V :
* . REPORTS 2019 THIRD QUARTER FINANCIAL RESULTS AND
OPERATIONAL
HIGHLIGHTS
* Q3 SALES C$2.908 MILLION
* QTRLY LOSS PER SHARE $0.00
* WORKING CAPITAL BALANCE OF $4.1MLN AS OF SEPTEMBER 30,
2019
Source text for Eikon: ID:nGNXbwz1Fh
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases